Nobuyuki Horita

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 32

Top Topics

Systematic Review

Computed Tomography

Coronavirus Disease

Tyrosine Kinase

Top Venues

Thoracic cancer

Therapeutic advances in medical oncology

Respirology (Carlton, Vic.)

Rheumatology advances in practice

This page only lists publications with an associated author ORCID identifier.

Publications

Ayami Kaneko, Nobuaki Kobayash, Kenji Miura, Hiromi Matsumoto, Kohei Somekawa, Tomofumi Hirose, Yukihito Kajita, Anna Tanaka, Shuhei Teranishi, Yu Sairenji, Hidetoshi Kawashima, Kentaro Yumoto, Toshinori Tsukahara, Nobuhiko Fukuda, Ryuichi Nishihira, Keisuke Watanabe, Nobuyuki Horita, Yu Hara, Makoto Kudo, Naoki Miyazawa, Takeshi Kaneko
Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancer. Thoracic cancer 15 (15) (2024)
Yuma Kawaguchi, Shingo Kato, Nobuyuki Horita, Daisuke Utsunomiya
Value of Dynamic Computed Tomography Myocardial Perfusion in CAD: A Systematic Review and Meta-analysis. European heart journal. Cardiovascular Imaging (2024)
Hao Chen, Masashi Ishihara, Hiroki Kazahari, Ryusuke Ochiai, Shigeru Tanzawa, Takeshi Honda, Yasuko Ichikawa, Nobuyuki Horita, Hisashi Nagai, Kiyotaka Watanabe, Nobuhiko Seki
Efficacy and safety of pharmacotherapy for cancer cachexia: A systematic review and network meta-analysis. Cancer medicine 13 (17) (2024)
Susu Zhou, Nobuyuki Horita, Theresa Shao, Matthew Harrington, Yu Fujiwara
Endocrine adverse events in patients with cancer receiving perioperative immune checkpoint blockade: a meta-analysis of randomized controlled trials. Therapeutic advances in medical oncology 16 (2024)
Ayami Kaneko, Nobuaki Kobayash, Kenji Miura, Hiromi Matsumoto, Kohei Somekawa, Tomofumi Hirose, Yukihito Kajita, Anna Tanaka, Shuhei Teranishi, Yu Sairenji, Hidetoshi Kawashima, Kentaro Yumoto, Toshinori Tsukahara, Nobuhiko Fukuda, Ryuichi Nishihira, Keisuke Watanabe, Nobuyuki Horita, Yu Hara, Makoto Kudo, Naoki Miyazawa, Takeshi Kaneko
Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancer. Thoracic cancer 15 (15) (2024)
Soichiro Adachi, Yohei Kirino, Kana Higashitani, Lisa Hirahara, Ayaka Maeda, Nobuyuki Horita, Kaoru Takase-Minegishi, Ryusuke Yoshimi, Hideaki Nakajima
Targeting enhanced cell death represents a potential therapeutic strategy for VEXAS syndrome. Rheumatology advances in practice 8 (2) (2024)
Susu Zhou, Nobuyuki Horita, Theresa Shao, Matthew Harrington, Yu Fujiwara
Endocrine adverse events in patients with cancer receiving perioperative immune checkpoint blockade: a meta-analysis of randomized controlled trials. Therapeutic advances in medical oncology 16 (2024)
Soichiro Adachi, Yohei Kirino, Kana Higashitani, Lisa Hirahara, Ayaka Maeda, Nobuyuki Horita, Kaoru Takase-Minegishi, Ryusuke Yoshimi, Hideaki Nakajima
Targeting enhanced cell death represents a potential therapeutic strategy for VEXAS syndrome. Rheumatology advances in practice 8 (2) (2024)
Yuma Kawaguchi, Shingo Kato, Nobuyuki Horita, Daisuke Utsunomiya
Value of Dynamic Computed Tomography Myocardial Perfusion in CAD: A Systematic Review and Meta-analysis. European heart journal. Cardiovascular Imaging (2024)
Ayami Kaneko, Nobuaki Kobayash, Kenji Miura, Hiromi Matsumoto, Kohei Somekawa, Tomofumi Hirose, Yukihito Kajita, Anna Tanaka, Shuhei Teranishi, Yu Sairenji, Hidetoshi Kawashima, Kentaro Yumoto, Toshinori Tsukahara, Nobuhiko Fukuda, Ryuichi Nishihira, Keisuke Watanabe, Nobuyuki Horita, Yu Hara, Makoto Kudo, Naoki Miyazawa, Takeshi Kaneko
Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancer. Thoracic cancer (2024)
Ayami Kaneko, Nobuaki Kobayash, Kenji Miura, Hiromi Matsumoto, Kohei Somekawa, Tomofumi Hirose, Yukihito Kajita, Anna Tanaka, Shuhei Teranishi, Yu Sairenji, Hidetoshi Kawashima, Kentaro Yumoto, Toshinori Tsukahara, Nobuhiko Fukuda, Ryuichi Nishihira, Keisuke Watanabe, Nobuyuki Horita, Yu Hara, Makoto Kudo, Naoki Miyazawa, Takeshi Kaneko
Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancer. Thoracic cancer 15 (15) (2024)
Naomi Tsuchida, Yuri Uchiyama, Ayaka Maeda, Nobuyuki Horita, Yohei Kirino, Naomichi Matsumoto
Comment on: Efficient detection of somatic UBA1 variants and clinical scoring system predicting patients with variants in VEXAS syndrome: reply. Rheumatology (Oxford, England) (2023)
Hiromi Matsumoto, Kohei Somekawa, Nobuyuki Horita, Suguru Ueda, Megumi Kaneko, Ayami Kaneko, Nobuhiko Fukuda, Ami Izawa, Chisato Kamimaki, Katsushi Tanaka, Kota Murohashi, Hiroaki Fuji, Yoichi Tagami, Ayako Aoki, Keisuke Watanabe, Yu Hara, Nobuaki Kobayash, Takeshi Kaneko
Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysis. Therapeutic advances in medical oncology 15 (2023)
Yoichi Tagami, Nobuyuki Horita, Megumi Kaneko, Suguru Muraoka, Nobuhiko Fukuda, Ami Izawa, Ayami Kaneko, Kohei Somekawa, Chisato Kamimaki, Hiromi Matsumoto, Katsushi Tanaka, Kota Murohashi, Ayako Aoki, Hiroaki Fujii, Keisuke Watanabe, Yu Hara, Nobuaki Kobayashi, Takeshi Kaneko
Whole-genome sequencing predicting phenotypic antitubercular drug resistance: meta-analysis. The Journal of infectious diseases (2023)
Kohei Somekawa, Nobuyuki Horita, Ayami Kaneko, Yoichi Tagami, Nobuhiko Fukuda, Hiromi Matsumoto, Ho Namkoong, Yu Fujiwara, Kaoru Minegishi, Takeshi Fukumoto, Keisuke Watanabe, Yu Hara, Nobuaki Kobayash, Takeshi Kaneko
Adverse events induced by nivolumab and ipilimumab combination regimens. Therapeutic advances in medical oncology 14 (2022)
Akihiro Ohmoto, Yu Fujiwara, Nobuyuki Horita, Kenji Nakano, Shunji Takahashi
Platinum-doublet chemotherapy for advanced gastroenteropancreatic neuroendocrine carcinoma: a systematic review and meta-analysis. Discover. Oncology 13 (1) (2022)
Nobuyuki Horita, Takeshi Fukumoto
Two years of the pandemic suppressed deaths from non-COVID-19 respiratory infections: A nationwide surveillance in Japan. Respirology (Carlton, Vic.) (2022)
Hao Chen, Seigo Katakura, Nobuyuki Horita, Ho Namkoong, Ikuma Kato, Yu Hara, Nobuaki Kobayash, Satoshi Fujii, Takeshi Kaneko
Immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung: a meta-analysis of diagnostic test accuracy. Therapeutic advances in medical oncology 14 (2022)
Miki Hoshi, Nobuaki Kobayash, Katsushi Tanaka, Kohei Somekawa, Ayami Kaneko, Ami Izawa, Kenichi Seki, Yoichi Tagami, Ayako Aoki, Hiroaki Fujii, Keisuke Watanabe, Nobuyuki Horita, Yu Hara, Mai Matsumura, Makiko Enaka, Maki Hagihara, Takeshi Kaneko
Diagnostic utility of transbronchial biopsy for Hodgkin's lymphoma: A case study. Thoracic cancer 12 (23) (2021)
Nobuyuki Horita, Etsuko Miyagi, Taichi Mizushima, Maki Hagihara, Chiaki Hata, Yuki Hattori, Narihiko Hayashi, Kuniyasu Irie, Hideyuki Ishikawa, Yusuke Kawabata, Yosuke Kitani, Noritoshi Kobayashi, Nobuaki Kobayashi, Yusuke Kurita, Yohei Miyake, Kentaro Miyake, Senri Oguri, Ichiro Ota, Ayako Shimizu, Masanobu Takeuchi, Akimitsu Yamada, Kojiro Yamamoto, Norio Yukawa, Munetaka Masuda, Nobuhiko Oridate, Yasushi Ichikawa, Takeshi Kaneko
Severe anaphylaxis caused by intravenous anti-cancer drugs. Cancer medicine 10 (20) (2021)
Nobuaki Kobayash, Seigo Katakura, Chisato Kamimaki, Kohei Somekawa, Nobuhiko Fukuda, Katsushi Tanaka, Keisuke Watanabe, Nobuyuki Horita, Yu Hara, Hongmei Piao, Takeshi Kaneko
Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer patients: A meta-analysis. Thoracic cancer 12 (7) (2021)
Nobuyuki Horita, Hideaki Kato, Keisuke Watanabe, Yu Hara, Nobuaki Kobayashi, Takeshi Kaneko
Declined mortality due to seasonal influenza in Japan during the coronavirus disease 2019 pandemic. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Nobuyuki Horita, Hideaki Kato, Keisuke Watanabe, Yu Hara, Nobuaki Kobayash, Takeshi Kaneko
Decline in mortality due to respiratory diseases in Japan during the coronavirus disease 2019 pandemic. Respirology (Carlton, Vic.) (2021)
Nobuhiko Fukuda, Nobuyuki Horita, Ho Namkoong, Ayami Kaneko, Kohei Somekawa, Yoichi Tagami, Keisuke Watanabe, Yu Hara, Nobuaki Kobayash, Takeshi Kaneko
Best regimens for treating chemo-naïve incurable squamous non-small cell lung cancer with a programmed death-ligand 1 tumor proportion score of 1%-49%: A network meta-analysis. Thoracic cancer (2021)
Hiromi Matsumoto, Nobuaki Kobayash, Kohei Somekawa, Nobuhiko Fukuda, Ayami Kaneko, Chisato Kamimaki, Sousuke Kubo, Katsushi Tanaka, Yoichi Tagami, Shuhei Teranishi, Keisuke Watanabe, Nobuyuki Horita, Yu Hara, Masaki Yamamoto, Makoto Kudo, Harumi Koizumi, Kenji Miura, Naoki Miyazawa, Takeshi Kaneko
Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non-small-cell lung cancer: A multicenter retrospective trial. Thoracic cancer (2021)
Ayako Aoki, Yu Hara, Koji Okudela, Yoshihiro Ishikawa, Kosei Doshita, Hisashi Hashimoto, Kentaro Nakashima, Nobuyuki Horita, Nobuaki Kobayash, Takeshi Kaneko
Unusual lung involvements of invasive mucinous adenocarcinoma with chylothorax. Thoracic cancer 11 (11) (2020)
Seigo Katakura, Nobuaki Kobayash, Hisashi Hashimoto, Chisato Kamimaki, Katsushi Tanaka, Sousuke Kubo, Kentaro Nakashima, Shuhei Teranishi, Saki Manabe, Keisuke Watanabe, Nobuyuki Horita, Yu Hara, Masaki Yamamoto, Makoto Kudo, Hongmei Piao, Takeshi Kaneko
MicroRNA-200b is a potential biomarker of the expression of PD-L1 in patients with lung cancer. Thoracic cancer 11 (10) (2020)
Risa Ebina-Shibuya, Nobuyuki Horita, Ho Namkoong, Takeshi Kaneko
National policies for paediatric universal BCG vaccination were associated with decreased mortality due to COVID-19. Respirology (Carlton, Vic.) 25 (8) (2020)
Risa Ebina-Shibuya, Nobuyuki Horita, Ho Namkoong, Takeshi Kaneko
Current national policies for infant universal bacille Calmette-Guérin vaccination were associated with lower mortality from coronavirus disease 2019. Clinical and experimental vaccine research 9 (2) (2020)
Hao Chen, Nobuyuki Horita, Kentaro Ito, Hideyuki Nagakura, Yu Hara, Nobuaki Kobayash, Masaki Yamamoto, Makoto Kudo, Takeshi Kaneko
Systematic review of first-line chemotherapy for chemo-naïve extensive-stage small-cell lung cancer: network meta-analysis. Therapeutic advances in medical oncology 12 (2020)
Nobuaki Kobayash, Hisashi Hashimoto, Chisato Kamimaki, Ryo Nagasawa, Katsushi Tanaka, Sousuke Kubo, Seigo Katakura, Hao Chen, Nobuyuki Hirama, Ryota Ushio, Ayako Aoki, Kentaro Nakashima, Shuhei Teranishi, Saki Manabe, Hiroki Watanabe, Nobuyuki Horita, Keisuke Watanabe, Yu Hara, Masaki Yamamoto, Makoto Kudo, Hongmei Piao, Takeshi Kaneko
Afatinib + bevacizumab combination therapy in EGFR-mutant NSCLC patients with osimertinib resistance: Protocol of an open-label, phase II, multicenter, single-arm trial. Thoracic cancer 11 (8) (2020)
Masaru Ito, Nobuyuki Horita, Akimichi Nagashima, Takeshi Kaneko
Carboplatin plus pemetrexed for the elderly incurable chemo-naive nonsquamous non-small cell lung cancer: Meta-analysis. Asia-Pacific journal of clinical oncology 15 (2) (2018)